Dengue Type-2 Virus Envelope Protein Made Using Recombinant Baculovirus Protects Mice against Virus Challenge

Robert FeighnyDepartment of Virus Diseases, Walter Reed Army Institute of Research, Washington, District of Columbia

Search for other papers by Robert Feighny in
Current site
Google Scholar
PubMed
Close
,
Jeanne BurrousDepartment of Virus Diseases, Walter Reed Army Institute of Research, Washington, District of Columbia

Search for other papers by Jeanne Burrous in
Current site
Google Scholar
PubMed
Close
, and
Robert PutnakDepartment of Virus Diseases, Walter Reed Army Institute of Research, Washington, District of Columbia

Search for other papers by Robert Putnak in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

The gene coding for the envelope (E) glycoprotein of dengue-2 virus was cloned into baculovirus (Autographa californica nuclear polyhedrosis virus). The recombinant virus contained the entire E protein gene, preceded by 38 nucleotides from the end of the prematrix glycoprotein gene and followed by the first 83 nucleotides of nonstructural protein 1. When expressed in Spodoptera frugiperda (Sf9) cells, approximately 1 mg of recombinant E antigen was made per 109 cells. This antigen reacted with polyclonal, antidengue type-2 antibody and a dengue type-2-specific, neutralizing monoclonal antibody. BALB/c mice immunized with the recombinant antigen produced only non-neutralizing antibody against dengue-2 virus, but were partially protected against morbidity and mortality after intracranial challenge with virulent dengue-2 virus.

Author Notes

Deceased.

Save